GLIOBLASTOMA MULTIFORME: CURRENT CHALLENGES IN DIAGNOSIS, TREATMENT, AND FUTURE THERAPEUTIC STRATEGIES
Keywords:
Glioblastoma multiforme; glioblastoma; brain tumor; neuro-oncology; magnetic resonance imaging; immunotherapy; targeted therapy; molecular biomarkers; neurosurgery.Abstract
Glioblastoma multiforme (GBM) is the most aggressive and common primary malignant brain tumor in adults. Despite significant advances in neuro-oncology, neurosurgery, molecular biology, and medical imaging, glioblastoma remains associated with poor prognosis and high mortality rates. The tumor is characterized by rapid growth, extensive infiltration into surrounding brain tissue, marked genetic heterogeneity, and resistance to conventional therapies. Current treatment typically involves maximal surgical resection followed by radiotherapy and chemotherapy; however, recurrence is almost inevitable. Recent developments in molecular diagnostics, immunotherapy, targeted therapies, and gene-based treatments have generated new hope for improving outcomes. This article reviews the pathogenesis, epidemiology, clinical manifestations, diagnostic challenges, treatment approaches, and future therapeutic strategies for glioblastoma multiforme.
References
Uzbek Literature
Rahimov, R.A. Neyroxirurgiya asoslari. Toshkent: Yangi asr avlodi, 2021.
Karimov, H.Q. Klinik onkologiya va neyroonkologiya. Toshkent: Abu Ali ibn Sino nomidagi Tibbiyot nashriyoti, 2020.
Mamatqulov, M.A. Patologik anatomiya va markaziy nerv tizimi o‘smalari. Toshkent: Fan va texnologiya, 2019.
International Literature
National Cancer Institute. Glioblastoma Treatment and Research Updates. Bethesda, 2024.
European Association of Neuro-Oncology. Guidelines for the Diagnosis and Treatment of Glioblastoma. 2024.





